Inogen (INGN) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts INGN Hot Sheet
Join SI Premium – FREE
Inogen (NASDAQ: INGN) reported Q2 EPS of ($0.14), $0.03 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $95.1 million versus the consensus estimate of $95.05 million.
For earnings history and earnings-related data on Inogen (INGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zentalis Pharmaceuticals, Inc. (ZNTL) Misses Q2 EPS by 11c
- Cryoport (CYRX) Misses Q2 EPS by 1c
- Globus Medical (GMED) Tops Q2 EPS by 24c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
